Company: INGN
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0000950170-25-066966
Chunk: 1

Company: Inogen Inc
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 1
---
267

     16,594

     Deferred revenue - noncurrent
      
     5,107

     5,747

     Deferred tax liability
      
     7,409

     6,948

     Total liabilities
      
     110,460

     122,325

     Commitments and contingencies (Note 9)

     Stockholders' equity

     Common stock, $0.001 par value per share; 200,000,000 shares authorized; 26,887,242 and 23,902,338 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively
      
     27

     24

     Additional paid-in capital
      
     357,447

     328,174

     Accumulated deficit
      
     (159,011
     )

     (152,837
     )

     Accumulated other comprehensive loss
      
     (511
     )

     (1,501
     )

     Total stockholders' equity
      
     197,952

     173,860

     Total liabilities and stockholders' equity
     $
     308,412

     $
     296,185

See accompanying condensed notes to the consolidated financial statements.